Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 396,864	$ 351,185
Accounts receivable, net	279,011	206,442
Inventory	121,058	146,362
Prepaid assets	23,809	38,820
Restricted cash	1,373	1,114
Other current assets	11,782	22,408
Total current assets	833,897	766,331
Non-current assets:
Right-of-use assets	17,060	16,745
Property and equipment, net	3,379	4,345
Long-term inventory	46,080
Other assets	1,450	1,309
Total assets	901,866	788,730
Current liabilities:
Accounts payable	42,730	37,516
Accrued expenses	139,835	127,806
Current portion of development liability		75,830
Current portion of lease liabilities	6,792	6,441
Deferred revenue	1,903
Total current liabilities	191,260	247,593
Long-term liabilities:
Long-term development liability		239,817
Long-term credit facility	358,982
Convertible senior notes	93,263	93,033
Lease liabilities	11,411	11,454
Other liabilities	9,829	2,312
Total liabilities	664,745	594,209
Commitments and contingencies (Note 13)
Stockholders' equity:
Preferred stock, $0.0001 par value; 10,000 shares authorized, and zero shares issued and outstanding at September 30, 2024 and December 31, 2023	0	0
Common stock, $0.0001 par value; 200,000 shares authorized at September 30, 2024 and December 31, 2023; 122,069 shares issued and outstanding at September 30, 2024, and 119,556 shares issued and outstanding at December 31, 2023	12	12
Additional paid-in capital	3,239,262	3,035,539
Accumulated other comprehensive loss	(3,140)	(3,542)
Accumulated deficit	(2,999,013)	(2,837,488)
Total stockholders' equity	237,121	194,521
Total liabilities and stockholders' equity	$ 901,866	$ 788,730